1 completed, 1 terminated, 1 unknown. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow Placebo sublingual tablet: new trials by email Literature Review of Placebo sublingual tablet trials Research Report on Placebo sublingual tablet
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR) MELT-300 sublingual tablet, Midalozam sublingual tablet, Placebo sublingual tablet - Cataract | Phase 3 | Unknown | Melt Pharmaceuticals | 528 | 2024-05-01 | 2024-08-02 |
| A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber Sublingual allergy immunological tablet, Placebo - Allergic Rhinoconjunctivitis | Phase 3 | Terminated | ALK-Abelló A/S | 80 | 2019-11-04 | 2022-06-30 |
| House Dust Mite Allergy Trial In Children Sublingual allergy immunotherapy tablet, Placebo - Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus | Phase 3 | Completed | ALK-Abelló A/S | 1460 | 2019-10-12 | 2024-06-12 |
Rhinitis, Allergic (2) · Cataract (1) · Conjunctivitis, Allergic (1)
ALK-Abelló A/S (2) · Melt Pharmaceuticals (1)
United States (2) · Austria (1) · Bulgaria (1) · Canada (1) · China (1) · France (1) · Germany (1) · Lithuania (1) · Poland (1) · Russia (1) · Slovakia (1) · Spain (1) · Ukraine (1)
Antje Schuster, MD (1) · Luo Zhang, Prof. (1)